James Flynn
Board Member
Oruka Therapeutics, Inc. (ORKA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Flynn
James Flynn is recorded as Board Member at Oruka Therapeutics, Inc. (ORKA). Oruka Therapeutics, Inc. reported in an 8-K filed September 5, 2024 that James Flynn resigned as ARCA's board of directors, effective August 29, 2024. Oruka Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that James Flynn was appointed director, effective December 15, 2022.
“On August 29, 2024, Linda Grais, Anders Hove, Robert Conway, James Flynn and Jacob Ma-Weaver resigned from ARCA's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
“On December 15, 2022, the Board of Directors (the "Board") of ARCA biopharma, Inc. (the "Company") elected James Flynn, as a director of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-15–present
-
2022-12-15–2024-08-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Oruka Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Former Secretary General Counsel
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.